The Role of US28 During HCMV Latency
US28 在 HCMV 潜伏期中的作用
基本信息
- 批准号:8948751
- 负责人:
- 金额:$ 25.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAgonistAntiviral AgentsAreaBindingBiochemicalBiologicalBiological ProcessBiologyCD34 geneCREB1 geneCell Culture TechniquesCell Differentiation processCellsCoupledCytomegalovirusDataDevelopmentDiseaseEnvironmentExhibitsFetusFibroblastsG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesGoalsHematopoieticHematopoietic stem cellsHomologous GeneImmunocompromised HostIndividualInfectionInvestigationKnowledgeLeadLifeLyticLytic PhaseMaintenanceMediatingMessenger RNAMethodologyMethodsMolecularMyeloid Progenitor CellsOnset of illnessOutcomePathogenesisPathway interactionsPhasePopulationPositioning AttributeProcessPropertyProteinsProto-Oncogene Proteins c-aktPublic HealthRecombinantsRegulationResearchRoleSeveritiesSignal PathwaySignal TransductionSignaling MoleculeStagingTestingUnited StatesVaccinesViralViral PathogenesisVirionVirusVirus DiseasesVirus Latencychemokineexperiencehuman GPR4 proteininsightintercellular communicationlatency associated transcriptlatent infectionlytic replicationmonocytemutantnew therapeutic targetnovelpreventprogenitorpromoterpublic health relevancereactivation from latencyresearch and developmentresearch studytargeted treatmenttranscription factor
项目摘要
DESCRIPTION (provided by applicant): Human cytomegalovirus (HCMV) is a significant public health concern in the United States. Most important are the effects of the virus on developing fetuses and immunocompromised individuals where it causes a variety of pathological conditions ranging in severity from mild to life-threatening. Since HCMV is present in a persistent or latent form in 50-90% of the world's adult population, the identification of virl gene products that contribute to the establishment and maintenance of a latent infection is an intense and important area of investigation. HCMV encodes 4 GPCR homologs including US28, which has been shown to exhibit both constitutive and agonist-dependent G-protein signaling activities in HCMV infected fibroblasts. Although US28 exhibits high level signaling, it is not essential for lytic viral replication and therefore its function in viral pathogenesis remains unclear. Interestingly, US28 mRNAs are expressed in latently infected hematopoietic progenitors and monocytes, prompting questions regarding the potential role of US28 during latent CMV infections. Our exciting preliminary data indicates that US28 promotes a successful latent infection as US28 null viruses spontaneously enter the lytic phase in hematopoietic cells where wild type virus establishes a latent infection. Therefore, we hypothesize that US28 directed signaling in HCMV infected hematopoietic progenitors leads to the establishment and/or maintenance of latency. To explore this hypothesis, we will take advantage of a newly constructed panel of US28 mutant viruses and recently established methodologies to examine US28 signaling in HCMV infected cells. In Aim 1, we will examine the biological parameters by which US28 drives latency using viral recombinants in primary hematopoietic progenitor cells, and in Aim 2 we will examine the molecular signaling properties of US28 and determine which pathways contribute to the establishment and/or maintenance of latency. Finally, experiments like those proposed in this application are essential for our understanding of the role of CMV GPCRs in viral pathogenesis and will open novel avenues of research for the development of unique antivirals that specifically target the latent reservoir of virus infection.
描述(由申请人提供):人类巨细胞病毒 (HCMV) 是美国的一个重大公共卫生问题。最重要的是病毒对发育中的胎儿和免疫功能低下的个体的影响,它会导致各种病理状况,严重程度从轻微到危及生命。由于HCMV以持续或潜伏形式存在于世界上50-90%的成年人口中,因此鉴定有助于建立和维持潜伏感染的virl基因产物是一个激烈而重要的研究领域。 HCMV 编码 4 个 GPCR 同源物,包括 US28,已证明 US28 在 HCMV 感染的成纤维细胞中表现出组成型和激动剂依赖性 G 蛋白信号传导活性。尽管 US28 表现出高水平的信号传导,但它对于裂解病毒复制并不是必需的,因此其在病毒发病机制中的功能仍不清楚。有趣的是,US28 mRNA 在潜伏感染的造血祖细胞和单核细胞中表达,这引发了关于 US28 在潜伏 CMV 感染过程中潜在作用的问题。我们令人兴奋的初步数据表明,US28 促进成功的潜伏感染,因为 US28 无效病毒在造血细胞中自发进入裂解阶段,野生型病毒在该阶段建立潜伏感染。因此,我们假设 US28 在 HCMV 感染的造血祖细胞中定向信号传导导致潜伏期的建立和/或维持。为了探索这一假设,我们将利用新构建的 US28 突变病毒组和最近建立的方法来检查 HCMV 感染细胞中的 US28 信号传导。在目标 1 中,我们将检查 US28 在原代造血祖细胞中使用病毒重组体驱动潜伏期的生物学参数,在目标 2 中,我们将检查 US28 的分子信号传导特性,并确定哪些途径有助于潜伏期的建立和/或维持。最后,像本申请中提出的实验对于我们了解 CMV GPCR 在病毒发病机制中的作用至关重要,并将为开发专门针对潜在病毒感染库的独特抗病毒药物开辟新的研究途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTINE M O'CONNOR其他文献
CHRISTINE M O'CONNOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTINE M O'CONNOR', 18)}}的其他基金
HCMV GPCR functions during latency and reactivation
HCMV GPCR 在潜伏期和重新激活期间发挥作用
- 批准号:
10208088 - 财政年份:2021
- 资助金额:
$ 25.35万 - 项目类别:
HCMV GPCR functions during latency and reactivation
HCMV GPCR 在潜伏期和重新激活期间发挥作用
- 批准号:
10573318 - 财政年份:2021
- 资助金额:
$ 25.35万 - 项目类别:
Manipulation of host factors that promote HCMV latency
操纵促进 HCMV 潜伏期的宿主因素
- 批准号:
10372087 - 财政年份:2021
- 资助金额:
$ 25.35万 - 项目类别:
Manipulation of host factors that promote HCMV latency
操纵促进 HCMV 潜伏期的宿主因素
- 批准号:
10573191 - 财政年份:2021
- 资助金额:
$ 25.35万 - 项目类别:
HCMV GPCR functions during latency and reactivation
HCMV GPCR 在潜伏期和重新激活期间发挥作用
- 批准号:
10374921 - 财政年份:2021
- 资助金额:
$ 25.35万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 25.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 25.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)